Dorsavi Ltd

dorsaVi (ASX: DVL) has achieved a technical breakthrough in the evaluation of its robotic RRAM reflex platform, demonstrating that memory is no longer the bottleneck in achieving biological-grade reflexes. The platform has shown itself capable of delivering high-level reflexes faster than the human nervous system with minimal energy use. Testing also confirmed that intelligence is no […]

dorsaVi (ASX: DVL) has launched Artemis Labs, a wholly owned subsidiary focused on advancing robotics, artificial intelligence and sensor technologies. The new division will merge dorsaVi’s FDA-cleared movement analytics with resistive random-access memory (RRAM) technology licensed from Nanyang Technological University in Singapore. The company sees Artemis Labs acting as an innovation hub to extend human […]

An internal assessment of dorsaVi’s (ASX: DVL) resistive random access memory (RRAM) technology has confirmed its suitability for high-speed, low-power usage in embedded, wearable and AI-driven devices. Head-to-head comparisons with industry peers at the 40 nanometer (nm) node demonstrated the technology could offer highly-competitive speed, retention and endurance metrics. High-speed performance with up to 200 […]

Motion analysis device developer dorsaVi (ASX: DVL) has delivered its resistive random-access memory (RRAM)-powered sensor systems to Singapore for comprehensive testing in real-world biomedical contexts. Testing will focus on edge-device functionality under realistic conditions in applications where traditional NAND flash memory has struggled to meet the write demands of biosignal applications, creating bottlenecks for wearable […]